跳至主要内容
临床试验/IRCT2014120620218N1
IRCT2014120620218N1已完成2 期

Evaluation of the effect of Aspirin in pregnancy outcomes in patients with abnormal down syndrome biochemical tests and with normal karyotype

Vice chancellor for research, Kerman University of Medical Sciences0 个研究点目标入组 85 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • pregnant women with abnormal biochemical tests in second trimester which have normal karyotype; consent of the patients.
  • Exclusion criteria: history of sensitivity to aspirin; asthma; Peptic ulcer; renal failure; gout; multifetal pregnancy; gestational diabetes; hemorrhage in first half of pregnancy; maternal disorders; congenital anomalies.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Kerman University of Medical Sciences

相似试验